Evidence map›Paper›PMID 35690838›Full record

ReviewInfectious agents and cancer2022

Persistence and risk factors of high-risk human papillomavirus infection among HIV positive and HIV negative tanzanian women: a cohort study.

Patricia Swai, Vibeke Rasch, Ditte S Linde, Bariki Mchome, Rachel Manongi, Chun Sen Wu, Marianne Waldstrom, Thomas Iftner, Julius Mwaiselage, Susanne K Kjaer

Open access · goldAbstract readReview
In one paragraph

Review in Infectious agents and cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Patricia SwaiKilimanjaro Christian Medical Centre, 3060, Moshi, Tanzania. patriciaswai@yahoo.com.
Vibeke RaschUniversity of Southern Denmark, Odense, Denmark.
Ditte S LindeUniversity of Southern Denmark, Odense, Denmark.
Bariki MchomeKilimanjaro Christian Medical Centre, 3060, Moshi, Tanzania.
Rachel ManongiKilimanjaro Christian Medical Centre, 3060, Moshi, Tanzania.
Chun Sen WuUniversity of Southern Denmark, Odense, Denmark.
Marianne WaldstromDepartment of Pathology, Lillebaelt Hospital, Vejle, Denmark.
Thomas IftnerInstitute of Medical Virology, University Hospital of Tübingen, Tübingen, Germany.
Julius MwaiselageOcean Road Cancer Institute, Dar es Salaam, Tanzania.
Susanne K KjaerDanish Cancer Society Research Center, Unit of Virus, Lifestyle and Genes, Copenhagen, Denmark.
Kilimanjaro Christian Medical Centre · TZUniversity of Southern Denmark · DKDanish Cancer Society · DKLillebaelt Hospital · DKOcean Road Cancer Institute · TZOdense University Hospital · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh-risk (HR) human papillomavirus (HPV) persistence is the most important risk factor for cervical cancer. We have assessed the type-specific HR HPV persistence among HIV positive and HIV negative Tanzanian women and factors associated with HR HPV persistence.

methodsIn a cohort study including 4080 Tanzanian women, 3074 attended follow-up examination (up to 32 months after enrollment). Cervical samples were obtained for liquid-based cytology and HPV DNA testing using Hybrid Capture 2 and Inno-Lipa Extra II. Information on lifestyle factors was collected through a personal interview. The probability of HR HPV persistence at a given time point since enrollment was estimated non-parametrically using the EMICM algorithm.

resultsAmong the 462 women HR HPV positive at enrollment, 158 had at least one identical type detected at follow-up. The probability of persistence at 18 months after enrollment was 34.2 (95% CI 29.0-39.4). Stratifying by HIV status, the persistence probability was 42.9% (95% CI 33.5-51.9) among HIV positive, and 28.0% (95% CI 22.1-34.2) among HIV negative. Overall, HR HPV persistence was most common for HPV58, 35, 16, 31, and 52. Among HIV positive women it was HPV45, and HPV16, followed by HPV58 and HPV18, and among HIV negative women it was HPV31, HPV33 and HPV58. Risk factors associated with persistence of HR HPV were older age, longer interval between enrollment and follow-up, binge drinking, and HIV status.

conclusionsHR HPV persistence was common in Tanzania, and most common among HIV positive women. Overall, persistence was most frequent for HPV 58, 35, 16, 31 and 52. The nonavalent HPV vaccine should be considered.

Indexed as

HIV statusHR HPVPersistenceRisk factorsTanzania

Identifiers

PMID35690838
PMCPMC9188099
OpenAlexW4282930572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.